357
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Impact of grinding balls on the size reduction of Aprepitant in wet ball milling procedure

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 353-358 | Received 13 Jan 2023, Accepted 21 Mar 2024, Published online: 08 Apr 2024

References

  • Al-Kassas R, Bansal M, Shaw J. 2017. Nanosizing techniques for improving bioavailability of drugs. J Control Release. 260:202–212. doi: 10.1016/j.jconrel.2017.06.003.
  • Bosch HW, Liversidge E, Shelukar SD, Thompson KC. 2012. Pharmaceutical composition of a tachykinin receptor antagonist. U.S. Patent 8,258,132.
  • Douroumis D, Ross SA, Nokhodchi A. 2017. Advanced methodologies for cocrystal synthesis. Adv Drug Deliv Rev. 117:178–195. doi: 10.1016/j.addr.2017.07.008.
  • Ganesan P, Soundararajan R, Shanmugam U, Ramu V. 2015. Development, characterization and solubility enhancement of comparative dissolution study of second generation of solid dispersions and microspheres for poorly water soluble drug. Asian J Pharm Sci. 10(5):433–441. doi: 10.1016/j.ajps.2015.05.001.
  • Ghosh I, Schenck D, Bose S, Liu F, Motto M. 2013. Identification of critical process parameters and its interplay with nanosuspension formulation prepared by top down media milling technology–a QbD perspective. Pharm Dev Technol. 18(3):719–729. doi: 10.3109/10837450.2012.723720.
  • Junyaprasert VB, Morakul B. 2015. Nanocrystals for enhancement of oral bioavailability of poorly water-soluble drugs. Asian J Pharm Sci. 10(1):13–23. doi: 10.1016/j.ajps.2014.08.005.
  • Khadka P, Ro J, Kim H, Kim I, Kim JT, Kim H, Cho JM, Yun G, Lee J. 2014. Pharmaceutical particle technologies: an approach to improve drug solubility, dissolution and bioavailability. Asian J Pharm Sci. 9(6):304–316. doi: 10.1016/j.ajps.2014.05.005.
  • Kim DH, Kim YW, Tin YY, Soe MT, Ko BH, Park SJ, Lee JW. 2021. Recent technologies for amorphization of poorly water-soluble drugs. Pharmaceutics. 13(8):1318. doi: 10.3390/pharmaceutics13081318.
  • Kumar S, Kaur R, Rajput R, Singh M. 2018. Bio-Pharmaceutics Classification System (BCS) class IV drug nanoparticles: quantum leap to improve their therapeutic index. Adv Pharm Bull. 8(4):617–625. doi: 10.15171/apb.2018.070.
  • Li M, Yaragudi N, Afolabi A, Dave R, Bilgili E. 2015. Sub-100 nm drug particle suspensions prepared via wet milling with low bead contamination through novel process intensification. Chem Eng Sci. 130:207–220. doi: 10.1016/j.ces.2015.03.020.
  • Loh ZH, Samanta AK, Heng PWS. 2015. Overview of milling techniques for improving the solubility of poorly water-soluble drugs. Asian J Pharm Sci. 10(4):255–274. doi: 10.1016/j.ajps.2014.12.006.
  • Malamatari M, Taylor KM, Malamataris S, Douroumis D, Kachrimanis K. 2018. Pharmaceutical nanocrystals: production by wet milling and applications. Drug Discov Today. 23(3):534–547. doi: 10.1016/j.drudis.2018.01.016.
  • Narayan R, Pednekar A, Bhuyan D, Gowda C, Koteshwara K, Nayak UY. 2017. A top-down technique to improve the solubility and bioavailability of aceclofenac: in vitro and in vivo studies. Int J Nanomed. 12:4921–4935. doi: 10.2147/IJN.S141504.
  • Peltonen L. 2018. Design space and QbD approach for production of drug nanocrystals by wet media milling techniques. Pharmaceutics. 10(3):104. doi: 10.3390/pharmaceutics10030104.
  • Rostamkalaei SS, Akbari J, Saeedi M, Morteza-Semnani K, Nokhodchi A. 2019. Topical gel of metformin solid lipid nanoparticles: a hopeful promise as a dermal delivery system. Colloids Surf B Biointerfaces. 175:150–157. doi: 10.1016/j.colsurfb.2018.11.072.
  • Shono Y, Jantratid E, Kesisoglou F, Reppas C, Dressman JB. 2010. Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans. Eur J Pharm Biopharm. 76(1):95–104. doi: 10.1016/j.ejpb.2010.05.009.
  • Srivalli KMR, Mishra B. 2016. Drug nanocrystals: a way toward scale-up. Saudi Pharm J. 24(4):386–404. doi: 10.1016/j.jsps.2014.04.007.
  • Wu W, Löbmann K, Rades T, Grohganz H. 2018. On the role of salt formation and structural similarity of co-formers in co-amorphous drug delivery systems. Int J Pharm. 535(1–2):86–94. doi: 10.1016/j.ijpharm.2017.10.057.